Global Bacteriophage Market Growth (Status and Outlook) 2024-2030

Global Bacteriophage Market Growth (Status and Outlook) 2024-2030

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The global Bacteriophage market size is projected to grow from US$ 51.2 million in 2024 to US$ 153 million in 2030; it is expected to grow at a CAGR of 20.0% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Bacteriophage Industry Forecast” looks at past sales and reviews total world Bacteriophage sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophage sales for 2023 through 2029. With Bacteriophage sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophage industry.

This Insight Report provides a comprehensive analysis of the global Bacteriophage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bacteriophage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophage market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophage and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophage.

Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophage market by product type, application, key players and key regions and countries.

Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others

Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others

Segmentation by Application:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage

Please note: The report will take approximately 2 business days to prepare and deliver.